Ła patofisiologia del cancro al polmone se riferise ai canbi nei normali processi e mecanismi fisiologici che se verifica nel sviłupo e progression del cancro al polmone.
El cancro ai polmoni xe 'na malatia complessa che nasse dała cressita e divixion incontrolà de sèłułe anormałi nei polmoni.
Ste cellule łe pol formar tumori e spargerse in altre parti del corpo, portando a vari sintomi e complicazioni.
Ła patofisiologia del cancro ai polmoni coinvolge diversi fatori, tra cui mutassioni genetiche, fatori ambientałi e scelte de stiłe de vita.
Łe mutassioni genetiche łe pol capitar nel DNA dełe cellule polmonari, portando a na crésita e divixion cellulare incontrolà.
Ste mutassiòn łe pol esar ereditàe o aquistae, e łe pol esar causà da l'esposiziòn a sostanse cancerogene, come el fumo de tabaco, el radon, l'amianto e l'inquinamento de l'aria.
El cancro al polmone pol essar clasificà in do tipi prinsipałi: cancro al polmone a piccole cellule (SCLC) e cancro al polmone non a piccole cellule (NSCLC).
Ła patofisiologia de sti tipi de cancro polmonare pol esar diversa, parché i ga diverse mutassioni genetiche e i risponde in modo diverso al tratamento.
Ła patofisiologia del cancro al polmone ła coinvolge anca l'interasion tra łe sèłułe canceróxe e el tesùo circostante, incluso el sistema immunitario.
Łe celule cancerose łe pol scampar al sistema immunitario, permetendołe de cressar e difondarse sensa controło.
Inoltre, el microambiente del tumore pol promóvar ła crésita del tumore e ła metastasi fornendo un ambiente favorevołe ałe celule tumorałi.
La fisiopatologia del cancro al polmone xe un processo conpleso e dinamico e i ricercatori i xe drio a lavorar continuamente pa capir mejo i mecanismi fondamentałi pa sviłupar cure pì efficaci e migliorar i risultati dei pasienti.
Li Z, Qian Y, Li W, Liu L, Yu L, Liu X, Wu G, Wang Y, Luo W, Fang F, Liu Y, Song F, Cai Z, Chen W, Huang W: Human Lung Adenocarcinoma-Derived Organoid Models for Drug Screening. iScience. 2020, 23 (8): 101411.
Nurwidya F, Syahruddin E, Yunus F: Pain management in lung cancer. Adv Respir Med. 2016, 84 (6): 331-336.
Khan KA, Kennedy MP, Moore E, Crush L, Prendeville S, Maher MM, Burke L, Henry MT: Radiological characteristics, histological features and clinical outcomes of lung cancer patients with coexistent idiopathic pulmonary fibrosis. Lung. 2015, 193 (1): 71-7.
Paramanantham A, Asfiya R, Das S, McCully G, Srivastava A: Extracellular Vesicle (EVs) Associated Non-Coding RNAs in Lung Cancer and Therapeutics. Int J Mol Sci. 2022, 23 (21): .
Lee D, Kim Y, Chung C: Scientific Validation and Clinical Application of Lung Cancer Organoids. Cells. 2021, 10 (11): .
Mucchietto V, Crespi A, Fasoli F, Clementi F, Gotti C: Neuronal Acetylcholine Nicotinic Receptors as New Targets for Lung Cancer Treatment. Curr Pharm Des. 2016, 22 (14): 2160-9.
['Disclaimer: medego']
['Sto sito web el xe fornìo solo par scopi educativi e informativi e no el costituise un consejo mèdego o servisi profesionali.']
['Łe informasion fornìe no łe ga da esar usà pa diagnosticar o curar un problema de salute o na malatia, e chi che serca un consijo mèdego personal el ga da consultar un mèdego licensià.']
['Te prego de notare che a rete neurałe che ła genera risposte ałe domande, ła xe particołarmente imprecisa quando se trata de contenuti numèrici, par exenpio el nùmaro de persone a cui xe stà diagnosticà na determinada małatia.']
['Serca senpre el consijo del to dotor o de un altro fornitor de sałute cualificà riguardo a na condision mèdega. Mai trascurar el consijo mèdego profesionałe o ritardarlo nel sercarlo par via de calcossa che te ghè leto su sto sito. Se te pensi de aver na emergensa mèdega, ciama el 911 o va al pronto socorso pì visin imediatamente.']
['Disclaimer: copyright']
['El Digital Millennium Copyright Act del 1998, 17 U.S.C. § 512 (el DMCA) el dà ricorso ai proprietari de copyright che i crede che el material che vien fora su Internet infranga i so diriti soto ła lege sui copyright dei Stati Uniti. ']
["Se te credi in bona fede che un contenuto o un material messo a dispoxision in conesion col nostro sito o i nostri servisi infranga i to diriti de autor, ti (o el to agente) te pol mandarne na notisia domandando che el contenuto o el material sia rimoso, o che l'acesso sia blocà."]
['I avixi i ga da esare mandà par scrito via e-mail (varda ła sezion "Contato" pa\'l indiriso e-mail).']
["El DMCA richiede che a to notisia de presunta violasion de copyright includa e seguenti informasion: (1) descrixion del lavoro proteto da copyright che xe l'ogeto de ła presunta violasion; (2) descrixion del presunto contenuto che viola e informasion sufisente par permeterne a noi de localixar el contenuto; (3) informasion de contato, incluxo el to indirizo, numero de telefono e indirizo email; (4) na dichiarasion da parte tua che te credi in bona fede che el contenuto nel modo reclamà no xe autorizà dal proprietario del copyright, o dal so agente, o da l'operasion de nisuna lege; "]
["(5) 'na to dichiarasion, firmada soto pena de spergiuro, che łe informasion neła notìfega xe precise e che te ghè l'autorità de far valer i diriti de autor che i xe stai violadi;"]
['e (6) na firma fisica o ełetrònica del titołare del copyright o de na persona autorizada a agire a nome del titołare del copyright. ']
['Se no te meti tute łe informasion sora łe pol far in modo che el tratamento del to reclamo el se intardi.']
['Contato']
['Ve prego de mandarne na mail co qualsiasi domanda/suggerimento.']
What is pathophysiology of lung cancer?
The pathophysiology of lung cancer refers to the changes in the normal physiological processes and mechanisms that occur in the development and progression of lung cancer.
Lung cancer is a complex disease that arises from the uncontrolled growth and division of abnormal cells in the lungs.
These cells can form tumors and spread to other parts of the body, leading to various symptoms and complications.
The pathophysiology of lung cancer involves several factors, including genetic mutations, environmental factors, and lifestyle choices.
Genetic mutations can occur in the DNA of lung cells, leading to uncontrolled cell growth and division.
These mutations can be inherited or acquired, and they can be caused by exposure to carcinogens, such as tobacco smoke, radon, asbestos, and air pollution.
Lung cancer can be classified into two main types: small cell lung cancer (SCLC) and non-small cell lung cancer (NSCLC). NSCLC is further divided into three subtypes: adenocarcinoma, squamous cell carcinoma, and large cell carcinoma.
The pathophysiology of these types of lung cancer can differ, as they have different genetic mutations and respond differently to treatment.
The pathophysiology of lung cancer also involves the interaction between cancer cells and the surrounding tissue, including the immune system.
Cancer cells can evade the immune system, allowing them to grow and spread unchecked.
Additionally, the tumor microenvironment can promote tumor growth and metastasis by providing a supportive environment for cancer cells.
The pathophysiology of lung cancer is a complex and dynamic process, and researchers are continuously working to better understand the underlying mechanisms to develop more effective treatments and improve patient outcomes.
Disclaimer: medical
This web site is provided for educational and informational purposes only and does not constitute providing medical advice or professional services.
The information provided should not be used for diagnosing or treating a health problem or disease, and those seeking personal medical advice should consult with a licensed physician.
Please note the neural net that generates answers to the questions, is specially inaccurate when it comes to numeric content. For example, the number of people diagnosed with a specific disease.
Always seek the advice of your doctor or other qualified health provider regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website. If you think you may have a medical emergency, call 911 or go to the nearest emergency room immediately. No physician-patient relationship is created by this web site or its use. Neither BioMedLib nor its employees, nor any contributor to this web site, makes any representations, express or implied, with respect to the information provided herein or to its use.
Disclaimer: copyright
The Digital Millennium Copyright Act of 1998, 17 U.S.C. § 512 (the “DMCA”) provides recourse for copyright owners who believe that material appearing on the Internet infringes their rights under U.S. copyright law. If you believe in good faith that any content or material made available in connection with our website or services infringes your copyright, you (or your agent) may send us a notice requesting that the content or material be removed, or access to it blocked. Notices must be sent in writing by email (see 'Contact' section for email address) . The DMCA requires that your notice of alleged copyright infringement include the following information: (1) description of the copyrighted work that is the subject of claimed infringement; (2) description of the alleged infringing content and information sufficient to permit us to locate the content; (3) contact information for you, including your address, telephone number and email address; (4) a statement by you that you have a good faith belief that the content in the manner complained of is not authorized by the copyright owner, or its agent, or by the operation of any law; (5) a statement by you, signed under penalty of perjury, that the information in the notification is accurate and that you have the authority to enforce the copyrights that are claimed to be infringed; and (6) a physical or electronic signature of the copyright owner or a person authorized to act on the copyright owner’s behalf. Failure to include all of the above information may result in the delay of the processing of your complaint.
['Circa']
['BioMedLib usa computer automatici (algoritmi de machine-learning) pa generar coppie de domande e risposte.']
['Cominsiemo co 35 milioni de publicassioni biomediche de PubMed/Medline. e anca pagine web de RefinedWeb.']
